Fate Therapeutics Inc (FATE)

CIK 1434316 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Fate Therapeutics Inc.

Recent SEC filings

FiledFormAccession number
Nov 5, 20268-K0001193125-26-449840
Nov 5, 2026S-30001193125-26-450034
Nov 5, 202610-Q0001193125-26-448543
Nov 5, 2026424B50001193125-26-450013
Nov 5, 20268-K0001193125-26-448530
Nov 4, 202640001193125-26-447171
Nov 3, 20261440001959173-26-007696
Sep 28, 20268-K0001193125-26-403429
Aug 13, 2026S-80001193125-26-349151
Aug 13, 20268-K0001193125-26-347984
Aug 13, 202610-Q0001193125-26-347988
Aug 5, 202640001193125-26-335007
Aug 5, 202640001193125-26-335019
Aug 4, 20261440001959173-26-005627
Aug 4, 20261440001959173-26-005625
Jul 8, 2026SCHEDULE 13G/A0002012383-26-001939
Jun 15, 202630001193125-26-271062
Jun 15, 202640001193125-26-271088
Jun 15, 202640001104659-26-074130
Jun 15, 202640001193125-26-271083
Jun 15, 202640001193125-26-271072
Jun 15, 20268-K0001193125-26-271055
Jun 15, 202640001193125-26-271079
Jun 15, 202640001193125-26-271074
Jun 15, 202640001104659-26-074126